Payment overview · 2025
General Payments
$32.63
2 reported records · 2 companies
Healthcare provider profile · identity verified
George Leonard Cain, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · CORINTH, MS · NPI 1790709079
Verified facts
What the public records show
CMS Open Payments records show George Leonard Cain, M.D. received $32.63 in general payments during 2025 across 2 reported records.
Novo Nordisk Inc accounted for 57.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $18.59 | 57.0% | 1 | 2025 |
| Alpha Cognition USA, Inc. | Unresolved — no canonical attribution shown | $14.04 | 43.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $32.63 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Zunveyl Normalized: zunveyl |
Drug | Alpha Cognition USA, Inc. | $14.04 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
51 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 677 | 49 |
| Amlodipine Besylate | Amlodipine Besylate | 448 | 89 |
| Atorvastatin Calcium | Atorvastatin Calcium | 431 | 63 |
| Alprazolam | Alprazolam | 427 | 66 |
| Gabapentin | Gabapentin | 402 | 62 |
| Omeprazole | Omeprazole | 389 | 70 |
| Levothyroxine Sodium | Levothyroxine Sodium | 384 | 67 |
| Pantoprazole Sodium | Pantoprazole Sodium | 364 | 59 |
| Lisinopril | Lisinopril | 357 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 335 | 51 |
| Metformin Hcl | Metformin Hcl | 325 | 51 |
| Furosemide | Furosemide | 324 | 67 |
| Tamsulosin Hcl | Tamsulosin Hcl | 290 | 61 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 284 | 59 |
| Potassium Chloride | Potassium Chloride | 248 | 44 |
| Losartan Potassium | Losartan Potassium | 230 | 47 |
| Eliquis | Apixaban | 209 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 208 | 33 |
| Famotidine | Famotidine | 206 | 30 |
| Simvastatin | Simvastatin | 204 | 31 |
| Buspirone Hcl | Buspirone Hcl | 198 | 28 |
| Montelukast Sodium | Montelukast Sodium | 193 | 35 |
| Meloxicam | Meloxicam | 174 | 42 |
| Trazodone Hcl | Trazodone Hcl | 148 | 34 |
| Clopidogrel | Clopidogrel Bisulfate | 141 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 137 | 24 |
| Levetiracetam | Levetiracetam | 134 | 12 |
| Tramadol Hcl | Tramadol Hcl | 126 | 29 |
| Tizanidine Hcl | Tizanidine Hcl | 117 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 116 | 18 |
| Zolpidem Tartrate | Zolpidem Tartrate | 115 | 23 |
| Azithromycin | Azithromycin | 113 | 83 |
| Sertraline Hcl | Sertraline Hcl | 112 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 111 | 39 |
| Ropinirole Hcl | Ropinirole Hcl | 108 | 13 |
| Carvedilol | Carvedilol | 106 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 104 | 19 |
| Clonazepam | Clonazepam | 93 | 18 |
| Olanzapine | Olanzapine | 93 | suppressed |
| Amoxicillin | Amoxicillin | 92 | 71 |
| Baclofen | Baclofen | 92 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 90 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 90 | 27 |
| Allopurinol | Allopurinol | 89 | 21 |
| Lamotrigine | Lamotrigine | 87 | suppressed |
| Lovastatin | Lovastatin | 80 | 13 |
| Sucralfate | Sucralfate | 80 | 12 |
| Aripiprazole | Aripiprazole | 78 | suppressed |
| Jardiance | Empagliflozin | 74 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 73 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 72 | 20 |
| Metformin Hcl Er | Metformin Hcl | 72 | 17 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 72 | 51 |
| Ezetimibe | Ezetimibe | 70 | 16 |
| Xarelto | Rivaroxaban | 69 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 66 | 11 |
| Pregabalin | Pregabalin | 65 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 63 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 62 | 13 |
| Memantine Hcl | Memantine Hcl | 62 | 12 |
| Warfarin Sodium | Warfarin Sodium | 62 | suppressed |
| Mirtazapine | Mirtazapine | 60 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 59 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 59 | 11 |
| Glimepiride | Glimepiride | 58 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 57 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 57 | suppressed |
| Ibuprofen | Ibuprofen | 56 | 15 |
| Metoprolol Tartrate | Metoprolol Tartrate | 56 | 14 |
| Cephalexin | Cephalexin | 55 | 38 |
| Prednisone | Prednisone | 55 | 26 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 54 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 53 | suppressed |
| Myrbetriq | Mirabegron | 53 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 52 | suppressed |
| Ozempic | Semaglutide | 51 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 51 | suppressed |
| Risperidone | Risperidone | 50 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 46 | suppressed |
| Januvia | Sitagliptin Phosphate | 43 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 42 | suppressed |
| Lorazepam | Lorazepam | 42 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 41 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 38 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 27 |
| Dicyclomine Hcl | Dicyclomine Hcl | 37 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 30 |
| Ventolin Hfa | Albuterol Sulfate | 37 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 35 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 34 | suppressed |
| Nifedipine Er | Nifedipine | 33 | suppressed |
| Nystatin | Nystatin | 33 | 14 |
| Promethazine Hcl | Promethazine Hcl | 33 | 12 |
| Clonidine Hcl | Clonidine Hcl | 32 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Fluconazole | Fluconazole | 31 | 17 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 31 | suppressed |
| Linzess | Linaclotide | 30 | suppressed |
| Topiramate | Topiramate | 30 | suppressed |
| Acyclovir | Acyclovir | 29 | 14 |
| Brilinta | Ticagrelor | 29 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 29 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 28 | 17 |
| Bupropion Hcl | Bupropion Hcl | 27 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Lansoprazole | Lansoprazole | 27 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 22 |
| Entresto | Sacubitril/Valsartan | 26 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 26 | 12 |
| Irbesartan | Irbesartan | 26 | suppressed |
| Lactulose | Lactulose | 26 | suppressed |
| Spironolactone | Spironolactone | 26 | suppressed |
| Celecoxib | Celecoxib | 25 | suppressed |
| Dutasteride | Dutasteride | 25 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 25 | suppressed |
| Atenolol | Atenolol | 24 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 24 | 18 |
| Divalproex Sodium Er | Divalproex Sodium | 24 | suppressed |
| Tradjenta | Linagliptin | 24 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 23 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 23 | 13 |
| Diazepam | Diazepam | 22 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Levofloxacin | Levofloxacin | 22 | 13 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 22 | suppressed |
| Methocarbamol | Methocarbamol | 22 | suppressed |
| Methylprednisolone | Methylprednisolone | 22 | 18 |
| Metolazone | Metolazone | 22 | suppressed |
| Theo-24 | Theophylline Anhydrous | 22 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 21 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 21 | suppressed |
| Haloperidol | Haloperidol | 21 | suppressed |
| Mupirocin | Mupirocin | 21 | 14 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 20 | suppressed |
| Bupropion Xl | Bupropion Hcl | 19 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 18 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Thioridazine Hcl | Thioridazine Hcl | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 15 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Gemtesa | Vibegron | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 14 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 11 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 11 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.63 · 2 records | Novo Nordisk Inc | Zunveyl | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error